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HIV infection and illicit drugs are known to induce oxidative stress and linked with
severity of viral replication, disease progression, impaired cell cycle regulation and
neurodegeneration. Studies have shown that morphine accelerates HIV infection and
disease progressionmediated by Reactive oxygen species (ROS). Oxidative stress impact
redox balance and ROS production affect cell cycle regulation. However, the role of
morphine in HIV associated acceleration of oxidative stress and its link to cell cycle
regulation and neurodegeneration has not been elucidated. The aim of present study is to
elucidate the mechanism of oxidative stress induced glutathione synthases (GSS), super
oxide dismutase (SOD), and glutathione peroxidase (GPx) impact cell cycle regulated
protein cyclin-dependent kinase 1, cell division cycle 2 (CDK-1/CDC-2), cyclin B, and cell
division cycle 25C (CDC-25C) influencing neuronal dysfunction by morphine co-morbidity
with HIV-1 gp120. It was observed that redox imbalance inhibited the GSS, GPx and
increased SOD which, subsequently inhibited CDK-1/CDC-2 whereas cyclin B and CDC-
25C significantly up regulated in HIV-1 gp120 with morphine compared to either HIV-1
gp120 or morphine treated alone in human microglial cell line. These results suggest that
HIV positive morphine users have increased levels of oxidative stress and effect of cell
cycle machinery, which may cause the HIV infection and disease progression.
Keywords: HIV-1 gp120, morphine, oxidative stress, cell cycle and microglia
Introduction
HIV infection is a major cause of human death and globally it was estimated that 35 million people
are living with HIV (UNAIDS/WHO, 2014). HIV comorbidity with illicit drugs remains a global
health problem. Illicit drugs of abuse including opiate is a significant risk factor forHIV infection and
AIDS disease progression (Hu et al., 2012; Masvekar et al., 2014; El-Hage et al., 2015). Opiate causes
deterioration of neuronal functions in a significant proportion of users resulting in the development
of neuronal impairments andHIV associated neurocognitive dysfunction (HAND). Previous studies
demonstrate that heroin is deacetylated to morphine, which can affect the central nervous system
(CNS), and is very often associated with HIV infection and activated macrophages/microglia, are
the major reservoir of viral replication and disease progression (Navia et al., 1986; Kure et al., 1990;
Brzezinski et al., 1997). HIV-1 infection is known to cause CNS dysfunction and primarily affects
microglial cells and subsequently impact astrocytes and neurons. Clinical observations suggest that
selective regions of brain such as the striatum and the hippocampus highly express opioid receptors
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and have been associated with increased viral titers in HIV-
infected patients (Mansour et al., 1987; Mansour and Watson,
1993).
The HIV-1 envelop protein, glycoprotein 120 (gp120) is
required for viral entry and it facilitates the viral replication
and disease progression mediated by oxidative stress, which
subsequently affects the CNS (Brenneman et al., 1994; Galicia
et al., 2002). Previous studies have shown that HIV-1 gp120
associated with increased secretion of inflammatory cytokines
and chemokines (Holguin et al., 2004), glutamate, arachidonic
acid and its metabolites prostaglandin E2 (PGE2) and 5-
lipoxygenase (5-LOX; Samikkannu et al., 2011), nitric oxide (NO)
and reactive oxygen species (ROS; Ronaldson and Bendayan,
2008; Lisi et al., 2014). In microglia, gp120 induces oxidative
stress, ROS, TNF-, and MCP-1 production and subsequently
leading to neuronal cell death (Guo et al., 2013). Also, morphine
was found to induce oxidative stress in in vitro as well as in
vivo (Kovacic and Cooksy, 2005; Ma et al., 2015). Studies have
also shown that morphine impaired cellular function mediated
by oxidative stress which affects the CNS (Moron et al., 2009;
Beltran-Campos et al., 2015).
Studies have documented that increased level of oxidative
stress and ROS is associated with HIV-associated neurocognitive
impairment (Shah et al., 2013). Free radicals H2O2 and O2 ,
induced by oxidative stress are known to generate cellular damage
in multiple diseases, including HIV/AIDS (Kashou and Agarwal,
2011). Glutathione (GSH) is a tri peptide and known to be
important cell protectant in intracellular anti-oxidant defense
mechanisms, and its reduced levels have been correlated with
impaired neuronal function (Aoyama et al., 2008). However,
oxidative stress and cell cycle reentry seems counterintuitive.
Previous report demonstrated that oxidative stress on the cell cycle
reveals that increased ROS-induced DNA damage is correlated
with cell cycle arrest (Pyo et al., 2013). However, whether ROS-
induced stress response undergoes growth arrest or apoptosis may
depend in part on where the cell resides in the cell cycle when
insulted. Extensive studies have consistently demonstrated that
morphine consumption and HIV infection further stimulate the
sensitivity and neuronal dysfunction severity that causes HAND
(Grigoryan et al., 2010; Masvekar et al., 2014). HIV infected
morphine users have synergistically potentiated viral replication
and disease progression as compared with HIV positive subjects
(Roy et al., 2011; Dutta and Roy, 2012; Masvekar et al., 2014;
El-Hage et al., 2015). Despite mounting evidence suggesting
morphine use may aggravate HIV infection, mechanistic studies
determining the mutual role of morphine and HIV infection on
cell cycle regulation and their role in neurodegeneration are yet to
be determined. Therefore, we have investigated the mechanism of
HIV-1gp120 induced oxidative stress altered cell cycle regulation
andmorphine co-morbidity accelerated effects in microglial cells.
In this study, we have investigated the effect of HIV-1 gp120 in
combination with morphine induced oxidative stress that affect
the redox expression in GSS, SOD, GPx, and cell cycle arrest in G0
phase leads CDK-1/CDC-/2, cyclin B, and CDC-25C associated
neuropathogenesis. We showed that morphine with HIV-1 gp120
exacerbates the oxidative stress and cell cycle arrest in microglial
mediated CNS dysfunction.
Materials and Methods
Cell Culture and Reagents
Cell culture reagents were purchased from Sciencell (Carlsbad,
CA, USA). The glutathione synthetase (GSS), super oxide
dismutase (SOD), glutathione peroxide (GPx), and CDC25C
antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). The mouse anti-cyclin B and CDK-
1/CDC-2 antibodies were purchased from BD Transduction
Laboratories (San Jose, CA, USA). The goat anti-rabbit
IgG and goat anti-mouse IgG antibodies were purchased
from Santa Cruz Biotechnology. The propidium iodide
was purchased from PD bioscience (San Jose, CA, USA).
Electrophoresis reagents were purchased from Bio-Rad
(Richmond, CA, USA), and nitrocellulose membranes were
purchased from Amersham Scientific, Piscataway, NJ, USA. All
other reagents were purchased from Sigma–Aldrich (St. Louis,
MO, USA).
HIV-1 gp120 Recombinant Proteins
The HIV-1 gp120 (Bal) protein was obtained from the NIH AIDS
Research and Reference Reagent Program. The recombinant
gp120 proteins were tested >95% purity.
Microglial Cell Line (CHEM-5) Cultures
In this study, we used immortalized microglial CHEM-5
cells. Microglial cells were maintained in Dulbecco’s Modified
Eagle Medium supplemented with fetal bovine serum to a
final concentration of 10% (catalog # 30- 2020) and 1%
antibiotic/antimycotic solution (Sigma-Aldrich, St. Louis, MO,
USA).
RNA Extraction and Real time Quantitative PCR
(qRT-PCR)
Total RNA from microglia was extracted using the Qiagen
RNAeasy mini kit (Invitrogen Life Technologies, Carlsbad,
CA, USA) by following the manufacturer’s instructions. The
total RNA (3 mg) was used for the synthesis of cDNA. The
amplification of cDNA was performed using specific primers for
GSS (Assay ID Hs00609286_m1), GPx (Hs01591589_m1), and
SOD (Hs00166575_m1); and b-actin (Hs99999903_m1) (Applied
Biosystems, Foster City, CA, USA) was used as a housekeeping
gene for quantifying real-time PCR. Relative abundance of each
mRNA species was assessed using brilliant Q-PCR master mix
from Stratagene usingMx3000P instrument that detects and plots
the increase in fluorescence versus PCR cycle number to produce
a continuous measure of PCR amplification. Relative mRNA
species expression was quantitated and the mean fold change in
expression of the target gene was calculated using the comparative
CT method (Transcript Accumulation Index, TAI = 2_DDCT). All
data were controlled for quantity of RNA input by performing
measurements on an endogenous reference gene, b-actin. In
addition, results on RNA from treated samples were normalized
to results obtained on RNA from the control, untreated
sample.
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FIGURE 1 | The kinetic studies of Morphine and HIV-1 gp120
protein impact redox dysfunction in GSS gene expression.
Microglia (1  106 cells/ml) were treated with (A) morphine (0–1000 nM)
and (B) HIV-1 gp120 (0–200 ng) for 24 h for dose response studies. RNA
was extracted, reverse transcribed, and subjected to quantitative
real-time PCR using specific primers for GSS and the housekeeping gene
b-actin. Data are expressed as the mean  SE of the TAI values from
three independent experiments.
Western Blot Analysis
To determine the GSS, SOD, GPx, CDK-1/CDC-2, cyclin
B, and CDC25C protein alterations in microglial control,
morphine, HIV-1 gp120 and morphine with HIV-1 gp120
treated cells, equal amount of total cellular protein were
resolved on a 4–15% gradient polyacrylamide gel electrophoresis,
transferred to a nitrocellulosemembrane and incubated with their
respective primary and secondary antibodies. Immunoreactive
bands were visualized using a chemiluminescence western
blotting system according to the manufacturers’ instructions
(Amersham).
Analysis of HIV-1 gp120 and Morphine Impact on Cell
Cycle Regulation
Morphine and HIV-1 gp120 induced DNA damage and cell cycle
arrest were analyzed by flow cytometry in FACS caliber (BD
Bioscience, San Jose, CA). Briefly, Microglial (5  105) were
separately treated withmorphine, HIV-1 gp120, andHIV-1 gp120
with morphine. Cells were harvested and washed twice with PBS.
The cells were fixed in 0.5% paraformaldehyde and stained with
PI solution after 24 h. The ModFit LT software program (Verity
Software House) was used to determine the distribution of cells in
subG0/G0 phase of the cell cycle.
Data Analysis
Statistical analysis was performed using GraphPad Prism- version
5. Differences between morphine, HIV-1 gp120 and morphine
with HIV-1 gp120 treated and control were calculated using two-
way ANOVAmethod. Values were expressed as mean standard
error and a significance level of p< 0.05 was used.
Results
HIV-1 gp120 and Morphine Induced Oxidative
Stress; and Redox Gene and Protein Expression
in Microglial Cells
It is known that HIV infection; HIV-1 gp120 protein and
morphine induced ROS production lead to cell death (Ronaldson
and Bendayan, 2008; Ma et al., 2015). However, no information is
available onHIV-1 gp120 andmorphine induced ROS production
and redox altered cell cycle arrest and neurodegeneration.
Therefore, we determined whether HIV-1 gp120 induce
redox expression, cell cycle regulation and neurodegeneration
are accelerated by morphine in microglia. Observed results
demonstrate that HIV-1 gp120 and morphine significantly
increased oxidative stress and subsequently inhibited the redox
expression in microglia. The data presented in Figures 1A,B
show the dose response in morphine- (0–1000 nm/ml) and
gp120—(0–200 ng/ml) treatment for 24 h and its effects on
GSS gene expression in microglia, as assessed using quantitative
real-time PCR. Microglia treated with morphine significantly
down regulated GSS gene expression at 100 nm (p < 0.01),
500 nm (p < 0.001) and 1000 nm (p < 0.0001) compared to
control. In HIV-1 gp120 effect on 50 ng (p < 0.01), 100 ng
(p < 0.001) and 200 ng (p < 0.0001) compared to control was
observed respectively. Figure 2 shows the effects of HIV-1 gp120,
morphine and HIV-1 gp120 with morphine impact on redox
gene GSS (A), SOD (B), and GPx (C) expression. These studies
showed that HIV-1 gp120 and morphine treatment inhibit the
levels of GSS and GPx whereas SOD significantly increased, and
the combination of HIV-1 gp120 with morphine accelerates these
effects compared with control. The present finding suggested that
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FIGURE 2 | HIV-1 gp120 and morphine effect on redox genes GSS,
SOD and GPx expression. Microglia (1  106 cells/ml) were treated with
HIV-1 gp120 (100 ng), morphine (0.5 mM) and HIV-1 gp120 with morphine.
Controls were maintained by drug free medium. The end of the incubation,
RNA was extracted and reverse transcribed followed by quantitative real
time PCR for GSS (A), SOD (B), GPx (C), and housekeeping b-actin specific
primers. Data are expressed as mean  SE of TAI values of three
independent experiments.
FIGURE 3 | HIV-1 gp120 with morphine effect on redox expression.
Microglia (1  106 cells/ ml) were treated with HIV-1 gp120 (100 ng), morphine
(0.5 mM) and combination of HIV-1 gp120 with morphine. Controls were
maintained by drug free medium. The end of the incubation, equal amount of
protein lysate were resolved by 4–15% SDS-PAGE and protein expression were
analyzed by Western blot showing GSS (A), SOD (B), and GPx (C). (D–F)
represented % densitometric values of GSS, SOD, and GPx protein levels (%
control). Data are expressed as mean  SE of three independent experiments.
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FIGURE 4 | HIV-1 gp120 with morphine effect on cell cycle
proteins. Microglia (1  106 cells/ml) were treated with HIV-1 gp120
(100 ng), morphine (0.5 mM) and combination of HIV-1 gp120 with
morphine. Controls were maintained by drug free medium. The end of
the incubation, equal amount of protein lysate were resolved by 4–15%
SDS-PAGE and protein expression were analyzed by Western blot
showing cycline B1 (A), CDK1 (B), and CDC25C (C). (D–F)
represented % densitometric values of Cyc-B1, CDK1, and CDC25C
protein levels (% control). Data are expressed as mean  SE of three
independent experiments.
HIV-1 gp120 with morphine effects are accelerated as compared
to either HIV-1 gp120 or morphine alone (Figures 2A–C).
Furthermore, we also examined whether HIV-1 gp120 induced
oxidative and redox protein regulation is accelerated bymorphine.
Figure 3 shows the effects of HIV-1 gp120, morphine and HIV-1
gp120 with morphine effects on redox protein GSS (A), SOD (B),
and GPx (C). These observed results confirm that HIV-1 gp120
induced redox changes were accelerated by morphine. Taken
together, these finding suggested that oxidative stress induced
redox changes in HIV infection along with morphine leads to
neurodegeneration.
HIV-1 gp120 and Morphine Effects Cell Cycle
Protein in Microglial cells
Oxidative stress is known to induce DNA damage and cell cycle
arrest. Therefore, we wanted to test whether exposure to HIV-1
gp120 protein affect cell cycle protein and neurodegeneration. In
the present study, HIV-1 gp120 with morphine treated microglial
cells showed a significant decrease in CDK-1/CDC-2 whereas
cyclin B and CDC25C increased protein expression at 24 h,
compared with either HIV-1 gp120 or morphine alone. Figure 4
shows HIV-1 gp120 with morphine effect on CDK1/CDC-2 (A),
cyclin B (B), and CDC-25C (C) protein expression as compared
to the control. These observations confirmed that morphine
accelerates HIV-1 gp120 induced cell cycle effect.
HIV-1 gp120 and Morphine Accelerates Cell
Cycle Arrest
HIV infection affects cell cycle regulation and ultimately leads
to CNS dysfunctions (Amini et al., 2004; Zhao and Elder, 2005;
Liu et al., 2007; Wang et al., 2010). Microglia is one of the major
reservoirs of HIV infection and target of illicit drugs in the CNS.
Therefore, we examined the effect of HIV-1 gp120 with morphine
on cell cycle regulation in microglia. Figure 4 showed that HIV-
1 gp120 and morphine treated microglia significantly inhibited
cells at subG0 and G0 phase as compared with either HIV-1
gp120 or morphine alone (Figure 5). This study suggested that
oxidative stress induced redox inhibition subsequently lead cell
cycle arrest and this effect might be accelerated by morphine
mediated neurodegeneration.
Discussion
Studies have shown that oxidative stress plays a wide role in
cellular function including immune and neuronal dysfunction,
behavioral impairments in HIV-infection and substance abuse
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FIGURE 5 | HIV-1 gp120 with morphine effect on cell
cycle progression. Microglia (1  106 cells/ml) were treated
with HIV-1 gp120 (100 ng), morphine (0.5 mM) and
combination of HIV-1 gp120 with morphine and its effect on
cell cycle transitions were analyzed by flow cytometry (A) and
cell cycle phase are expressed as % (B).
(Grigoryan et al., 2010; Masvekar et al., 2014); El-Hage et al.,
2015). The oxidative stress induced ROS production is associated
with HAD or HAND. Glutathione is an important player in the
regulation of redox functions in cellular homeostasis (Schafer and
Buettner, 2001). Studies have shown that HIV infection induced
oxidative stress and ROS production subsequently affect redox
proteins such as GSS, SOD and GPx in HIV infected patients and
morphine users (Herzenberg et al., 1997; Koutsilieri et al., 1997;
Bhaskar et al., 2015). However, overstimulation of ROS leads to
inhibition in redox statusGSH/GSSG (Koutsilieri et al., 1997), and
subsequently impact the cell cycle machinery in cyclin B, CDK-
1/CDC-2 and CDC-25C, which may play a vital role in neuronal
dysfunction and disease progression in HAD patients (Klein and
Ackerman, 2003; Morris et al., 2012). The CNS microglia cells
are the major reservoirs of HIV infection and disease progression;
they are modulated by cell cycle arrest induced by CDK-1/CDC-
2, cyclin B and CDC-25C that lead to neurodegeneration (Cernak
et al., 2005; Wang et al., 2008). However, there are no reports
on the effects of HIV-1 gp120 and morphine induced redox
imbalance that initiate cell cycle arrest and cellular mechanisms
of neurodegeneration. The observed results provide new insights
into the functional role of redox expression, which subsequently
affects cell cycle machinery in HIV-1 gp120 with morphine.
In the present study, we have demonstrated for the first
time that morphine, HIV-1 gp120 and HIV-1 gp120 with
morphine showed increased oxidative stress and inhibit redox
levels of GSS and GPx and, subsequently increased SOD
mRNA and protein expression (Figures 1–3), associated
with increased ROS production as compared to the control.
It is known that redox dysfunction and GSH/GSSG ratio
are the major players in maintaining cellular homeostasis.
These studies suggest that morphine with HIV–1 gp120 may
have an enhanced role of on oxidative stress as compared
to the control. This is consistent with earlier reports of
gp120 and morphine induced oxidative stress in microglia
and macrophages, respectively where activation of the redox
pathway has been observed (Bhat et al., 2004; Ronaldson and
Bendayan, 2008; Lisi et al., 2014). Also, studies have shown
that oxidative stress and redox impairments are associated with
cell cycle arrest and DNA damage in the cerebral cortex brain
regions (Klein and Ackerman, 2003). These studies further
confirm that the cell cycle process in sub G0 and G0 stage
are affected by morphine with HIV-1 gp120 and leading to
neurodegeneration.
Moreover, our results show that in morphine, HIV-1 gp120,
and morphine with HIV-1 gp120 induction of DNA damage and
cell cycle arrest (Figures 4 and 5) is associated with inhibition of
CDK-1/CDC-2 and subsequently increased cyclin B1 and CDC-
25C. The main observation in this report is that HIV-1 gp120,
and morphine with HIV-1 gp120 have higher impact on cell cycle
arrest in the G0 phase due to ROS production and subsequently
reduced the level of redox expression and CDK-1 inhibition.
However, theHIV positivemorphine users have higher ROS levels
and DNA damage. This suggests that there is an interactive role
between morphine and HIV that synergistically potentiates and
increases co-morbidity when compared to either morphine use or
HIV infection. These results confirm the previous report of HIV-1
gp120 induced cell cycle arrest in CD4+ T Cells (Kolesnitchenko
et al., 1995).
Previous studies demonstrated that HIV-Vpr and Nef proteins
affect cell cycle regulation which may impact cell cycle process
(Yang et al., 2002; Wen et al., 2007; Li et al., 2010). In the present
study, HIV-1 gp120 with morphine showed inhibition of CDK-
1/CDC-2 and subsequent activation of cyclin B1 and CDC-25C
protein as compared to the control. Also, cell cycle arrest in the
G0 phase inhibited CDK-1/CDC-2 phosphorylation in microglia
Frontiers in Microbiology | www.frontiersin.org June 2015 | Volume 6 | Article 6146
Samikkannu et al. Morphine accelerates HIV disease progression.
could lead to an enhanced DNA damages, which alters neuronal
function and resulting in neurodegeneration. Furthermore, it
is known that Gi/Gq-induced synergistic activation of ERK
and subsequently affect between Ca2+ and Src family tyrosine
kinases (Chan et al., 2005). However, Morphine and HIV-
1 gp120 also known to activate ERK and downstream effect
on CREB transcription mediated by Ca2+. Also, HIV-1 gp120
induced cell cycle arrest and these effects are accelerated by
morphine in additivemanner and this effect atGi/Gqphase. These
results suggest that viral replication in HIV infected microglial
play a wide role in neuronal dysfunction, once HIV-1 gp120
or morphine effects altered DNA damages and subsequently
increased CDC-25C in cell cycle arrest mediated by cyclin B.
Overall, the data provides evidence of interaction of morphine
and HIV-1 gp120 leading to increase in oxidative stress and
redox inhibition which is associated with increased levels of
DNA damage and subsequently affecting cell cycle process. Based
on these results, redox imbalance potentiates the HIV viral
replication and disease progression by impairing the neuronal
function, which may lead to neurodegeneration. The present
study supports some of earlier reports in the dysfunction of cell
cycle machinery and increased neurodegeneration in morphine
using HIV infected patients as well as in the presence of HIV
derived proteins (Krathwohl and Kaiser, 2004; Malik et al.,
2014).
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